Deep Intelligent Pharma launches AI CRO 6.0 for clinical trial workflows

Aug 4, 2026 · Issue 1 · 4 sources, 4 articles

Deep Intelligent Pharma has announced AI CRO 6.0. The product offers AI support across the full chain of clinical trial workflows.

Who is affected and how

pharmaceuticals

CRO services are being extended with AI, which affects the selection criteria for outsourced trial management.

Sources

• Deep Intelligent Pharma Introduces AI CRO 6.0 to Expand End-to-End AI Support Across Clinical Trial Workflows | FinancialContentfinancialcontent.com · Aug 4, 2026
• User | times-online.com - Deep Intelligent Pharma Introduces AI CRO 6.0 to Expand End-to-End AI Support Across Clinical Trial Workflowsbusiness.times-online.com · Aug 4, 2026
• News | postregister.com - Deep Intelligent Pharma Introduces AI CRO 6.0 to Expand End-to-End AI Support Across Clinical Trial Workflowsbusiness.am-news.com · Aug 4, 2026
• News | decaturdailydemocrat.com - Deep Intelligent Pharma Introduces AI CRO 6.0 to Expand End-to-End AI Support Across Clinical Trial Workflowsmarkets.financialcontent.com · Aug 4, 2026

Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.